Astera Labs, Inc.
NASDAQAstera Labs reported Q2 results on August 4 and the numbers matched the hype — now a wave of analyst upgrades is chasing a stock that already lapped the old consensus. The post-earnings analyst reaction is the dominant story this week. Most of the Street raised targets aggressively on August 5. Evercore ISI lifted to $452 from $297. Jefferies moved to $450 from $270. Needham raised…
Snapshot as of 6 Aug 2026
Astera Labs reported Q2 results on August 4 and the numbers matched the hype — now a wave of analyst upgrades is chasing a stock that already lapped the old consensus. The post-earnings analyst reaction is the dominant…
Astera Labs reports Q2 results today after a stunning one-week rally that has reset the entire earnings setup — the stock that looked like a recovery trade yesterday morning is now priced for a strong beat. The price…
Astera Labs reports Q2 results on August 4 having staged a partial recovery from last week's brutal selloff, and the positioning heading into the print is markedly less defensive than it was just days ago. The stock…
ALAB heads into its August 4 earnings report with a sharp, awkward gap between where the stock is trading and where analysts think it should be — and with options traders growing visibly more cautious after a brutal…
Astera Labs heads into the back half of June with a sharp split in its weekly story: a 30% gain over the past month, two major analyst target hikes in 48 hours, and then a 9.7% single-session sell-off on Tuesday that…
Astera Labs enters the second half of May with short sellers in full retreat and a wall of analyst upgrades pushing the stock to $244 — a 19% gain on the week and 40% higher than a month ago. Short sellers have been…
Astera Labs entered this week as a stock that had already doubled in a month. It leaves the week with the Street rushing to catch up after a clean earnings beat sent shorts covering and analysts hiking targets en…
Astera Labs reports its Q1 results today with an extraordinary backdrop: the stock has nearly doubled in a month while its own CEO has been selling into every uptick. The insider activity is hard to ignore. Founder and…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ALAB — free to start on ORTEX.
Sign up for free →Open ALAB on ORTEX